- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Kathy Oubre: COA Conference Allows for Exchange of Ideas to Improve Patient Care
The Community Oncology Alliance's annual conference is a space where industry experts and key opinion leaders can share ideas on improving patient care and advocate for community oncology, said Kathy Oubre, MS, chief operating officer at Pontchartrain Cancer Center.
The Community Oncology Alliance's annual conference is a space where industry experts and key opinion leaders can share ideas on improving patient care and advocate for community oncology, said Kathy Oubre, MS, chief operating officer at Pontchartrain Cancer Center.
To register for the virtual conference, click here.
Transcript:
What will you be presenting on at COA's 2020 Virtual Conference?
At this year's Community Oncology Alliance conference, I will be participating with other panelists to discuss top community oncology trends and issues as well as improving practice workflows and prior authorizations through the use of artificial intelligence.
Why should individuals register for the conference?
Whether virtual or in person, the annual Community Oncology Alliance conference is always a place for us to share ideas for improving patient care, discuss the unique challenges that we face, and ultimately advocate for community oncology.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
